Product Information: Wingspan® Stent System with Gateway® PTA Balloon Catheter*
Wingspan® Stent System with Gateway® PTA Balloon Catheter* is manufactured by Boston Scientific for Stryker Neurovascular.
This section includes summaries and PowerPoint Presentations related to studies on ICAD treatment.
Stryker has attempted to provide useful materials about studies that reflect, in a fair and balanced way, the relevant data on the product and disease state.
Wingspan Stent System HDE Study
Wingspan Stent System US Multicenter Registry: Periprocedural Results
Study: US Multi-Center Experience with the Wingspan® Stent System for the Treatment of Intracranial Atheromatous Disease – Periprocedural Results
Clinical Data Summary: Download PDF
PPT Presentation: Download PPT
Wingspan Stent System US Multicenter Registry: Subset Analysis
Wingspan Stent System NIH Registry: 70-99 percent Stenosis Analysis
Wingspan Stent System US Multicenter Registry: Long Term 14.2 Month Results
Other Treatment Options: SSYLVIA Study
Cerebrovascular Complications Risk Factor Analysis
WASID Secondary Analysis on Predictors of Stroke
Disclaimer *Humanitarian Device. The Wingspan® Stent System with Gateway® PTA Balloon Catheter is authorized by Federal Law for use in improving cerebral artery lumen diameter in patients with intracranial atherosclerotic disease, refractory to medical therapy, in intracranial vessels with ≤ 50 percent stenosis that are accessible to the system. The effectiveness of this device for this use has not been demonstrated. The Gateway PTA Balloon Catheter is indicated for balloon dilation of the stenotic portion of intracranial arteries prior to stenting for the purpose of improving intracranial perfusion. IRB Review Required.